N-acetylcysteine reduces oxidative stress on end-organs in an ischemia-reperfusion rat model

N-acetylcysteine reduces oxidative stress on end-organs in an ischemia-reperfusion rat model

Aim: In this study, we researched the effect of N-acetylcysteine (NAC) on parenchymal organs in ischemia-reperfusion injury in therat models.Material and Methods: Experimental animals divided into four groups: Sham group (Sh, n=6), Sham+NAC group (Sh+NAC, n=6),ischemia-reperfusion group (I/R, n=10) and N-acetylcysteine-given study group (I/R+NAC, n=10). For the Sham group and Sham +NAC group, only aortic exploration was performed. I/R group’s abdominal aortas were clamped just inferior to the renal artery for 4hours following. Then, the reperfusion period was allowed for one hour. I/R+NAC group received the same procedure as I/R groupand additionally treated with NAC intraperitoneally. After these procedures, all rats were sacrificed. The parenchymal organs wereexcised for biochemical, flow cytometric and histopathologic examination. The data were evaluated statistically.Results: In the I/R+NAC group, the MDA values in AC tissue were significantly lower than the I/R group (p:0.0032). MDA value inkidney tissue was significantly higher in the I/R group compared to the control groups (p:0.003). In the I/R+NAC group, the MDA valuewas significantly lower than the I / R group (p:0.0002). MPO values in lung tissue were found lower in the I/R+NAC group comparedto the I/R group, it was not statistically significant (p:0.4497). In the I/R+NAC group, it was found statistically significantly lowerthan both the control and I/R groups in Flow cytometric evaluation (p:0.0002). In histopathological evaluation, the leukocyte countobserved significantly higher in the I/R+NAC group compared to the control groups and was statistically significantly lower than theI/R group in histopathological evaluation (p:0,0004).Conclusion: NAC reduces ischemia and reperfusion injury in parenchymal organs and especially in the lungs in a rat model

___

  • 1. Takhtfooladi HA, Hesaraki S, Razmara F, et al. Effects of N-acetylcysteine and pentoxifylline on remote lung injury in a rat model of hind-limb ischemia/reperfusion injury. J Bras Pneumol 2016;42:9-14.
  • 2. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxiareoxygenation injury. Am J Physiol Cell Physiol 2002;282:227-41.
  • 3. Tangül SU, Çakmak AM, Çağlayan O, et al. Prevention of the harmful effects of free oxygen radicals by using N-acetylcysteine in testicular torsion. J Pediatr Urol 2019:30371-7.
  • 4. Seifi B, Kadkhodaee M, Delavari F, et al. Pretreatment with pentoxifylline and N-acetylcysteine in liver ischemia reperfusion-induced renal injury. Ren Fail.2012;34:610-5
  • 5. Guo DW, Wang CY, Shih HC. N-acetylcysteine and atorvastatin alleviates lung injury due to ischemiareperfusion injury in rats.J Chin Med Assoc 2019 ;82:909-14.
  • 6. Forgiarini LF, Forgiarini LA Jr, da Rosa DP, et al. N-acetylcysteine administration confers lung protection in different phases of lung ischaemiareperfusion injury. Interact Cardiovasc Thorac Surg 2014;19:894-9.
  • 7. Uysal AI, Ocmen E, Akan M, et al. The effects of remote ischemic preconditioning and N-acetylcysteine with remote ischemic preconditioning in rat hepatic ischemia reperfusion injury model. Biomed Res Int 2014;2014:892704.
  • 8. Cerqueira NF, Hussni CA, Yoshida WB, et al. Effects of pentoxifylline and n-acetylcysteine on injuries caused by ischemia and reperfusion of splanchnic organs in rats. Int Angiol 2008;27:512-21.
  • 9. Bartekova M, Barancik M, Ferenczyova K, et al. Beneficial Effects of N-acetylcysteine and N-mercaptopropionylglycine on Ischemia Reperfusion Injury in the Heart. Curr Med Chem 2018;25:355-66.
  • 10. Wang T, Qiao S, Lei S, et al. N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats. PLoS One 2011;6:23967.
  • 11. Umaroglu Ozturk S, Tireli E, Yılmazbayhan D, et al. The effect of L-carnitine on cardiac injury in an experimental aortic ischemia-reperfusion injury model. Turkish J Vascular Surgery 2018;27:142-9.
  • 12. van der Laan L, Oyen WJ, Verhofstad AA, et al. Soft tissue repair capacity after oxygen-derived free radical-induced damage in one hindlimb of the rat. J Surg Res 1997;72:60-9.
  • 13. Sen H, Deniz S, Yedekci AE, et al. Effects of dexpanthenol and N-acetylcysteine pretreatment in rats before renal ischemia/reperfusion injury. Ren Fail 2014;36:1570-4.
  • 14. Seifi B, Kadkhodaee M, Delavari F, et al. Pretreatment with pentoxifylline and N-acetylcysteine in liver ischemia reperfusion-induced renal injury. Ren Fail 2012;34:610-5.
  • 15. Cusumano G, Romagnoli J, Liuzzo G, et al. N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney. Transplant Proc 2015;47:2757-62.
  • 16. Ege T, Eskiocak S, Edis M, et al. The role of N-acetylcysteine in lower extremity ischemia/ reperfusions.J Cardiovasc Surg (Torino) 2006 ;47:563- 8.
  • 17. Koksal C, Bozkurt AK, Ustundag N, et al. Attenuation of acute lung injury following lower limb ischemia/ reperfusion: the pharmacological approach. J Cardiovasc Surg (Torino) 2006;47:445-9.
  • 18. Koksal C, Bozkurt AK, Cangel U, et al. Attenuation of ischemia/reperfusion injury by N-acetylcysteine in a rat hind limb model. J Surg Res. 2003;111:236-9.
  • 19. Tassiopoulos AK, Carlin RE, Gao Y, et al. Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities. J Vasc Surg 1997;26:647-56.
  • 20. Klausner JM, Paterson IS, Kobzik L, et al. Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited. Ann Surg 1989;209:219-24.
  • 21. Buege TA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-10.
  • 22. Schierwagen C, Bylund-Fellenius AC, Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 1990;23:179-86.
  • 23. Sochman J. N-acetylcysteine in acute cardiology: 10 years later: what do we know and what would we like to know?! J Am Coll Cardiol 2002;39:1422-8.
Annals of Medical Research-Cover
  • Yayın Aralığı: Aylık
  • Yayıncı: İnönü Üniversitesi Tıp Fakültesi
Sayıdaki Diğer Makaleler

Reasons for drop-out of peritoneal dialysis in pediatric patients: A single-center experience

Beltinge DEMİRCİOĞLU KILIÇ, Melek AKSAY URGUN

Evaluation of myocardial performance index in smokers

Sıho HİDAYET

Evaluation of red blood cell distribution width and mean platelet volume levels in hypertensive and non-hypertensive epistaxis patients

Levent ALBAYRAK, Atakan SAVRUN, Emre GÖKÇEN, İbrahim ÇALTEKİN, Dilek ATİK, Hasan Burak KAYA, Bilgehan DEMİR

Clinicopathologic features of operated gastric cancer patients, single center nine years experience

Sinan YOL, Erdal POLAT, Orhan UZUN, Aziz Serkan SENCER, Mürşit DİNCER, Mustafa DUMAN, Kamuran Cumhur DEGER, Hüseyin CİGİLTEPE, Ebubekir GUNDES, Durmus Ali CETIN, Ulas ADAY

Predictive value of red cell distrubition width and C reactive protein/albumin ratio in determining severe acute pancreatitis

Orkide KUTLU, Yasemin GÖKDEN

Is chirp more effective than click and tone-burst during oVEMP test?

Mehmet Hakan KORKMAZ, Banu BAS, Kemal KESEROGLU, Serap ER, Ali ÖZDEK

Evaluation of the effects of tadalafil on pain response in thermal plantar and dynamic plantar tests in rats

Duygu ALTINTAŞ AYKAN, Selma YAMAN

An exploratory study on healthcare sustainability in Turkey: Satisfaction with work environment and perceived barriers towards reducing the environmental impact of pathology operations

Isıl YILDIZ AKTAS

Changes in seroprevalence and acute infection rates after vaccination and herd immunity in a pediatric hospital in the Southeastern Anatolia region of Turkey: Effects of adding hepatitis a vaccine to the Extended National Immunization Program

Reyhan YİŞ, Mehmet Sait YILDIRIM

Pilonidal disease specimens of 905 patients revealed no malignancy, however we still insist on histopathological examination

Mehmet Eren YUKSEL, Melike ORDU